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CHAPTER I

INTRODUCTION

Osseous defects are often encountered in periodontal
disease.

Surgical elimination of infrabony osseous lesions

are generally performed by flap procedures which permit access to the underlying bone.

The infrabony lesion can be

treated by the subtractive techniques of osteoplasty and
osteoectomy in which bone is recontoured to an acceptable
architectural norm.

Other ways the infrabony lesion can be

treated are by_ nongraft reattachment procedures, and by
various implant or grafting techniques.
In the treatment of periodontal disease, it is generally accepted that pockets should be eliminated, shallow
sulci obtained, and physiologic contours established in
both the osseous tissue and the overlying mucogingival complex of tissue.

The definitive elimination of a periodon-

tal pocket is complicated by osseous defects.

The tooth's

ability to withstand functional stresses is compromised
with loss of alveolar support.

As stated, a number of pro-

cedures can be utilized to correct osseous defects, but only

1

2

reconstructive approaches have the potential to increase
the alveolar supporting apparatus.
In advanced periodontal disease, the osseous defects
may not lend themselves to corrective treatment by subtractive techniques or by nongraft reattachment procedures
alone.

In these situations osseous grafting assumes its

role as a therapeutic modality.
An ideal graft or implant material having biological
acceptability, clinical feasibility, minimum risk and maximal predictability has not yet been found.

Many different

graft materials have been tried.

Viable osseous grafts
2
include cortical autografts_, 1 bone blend, cancellous bone

and marrow grafts (intraoral and iliac crest),3· 4 variously
prepared iliac allografts.5' 6 These graft procedures require added patient procedures and discomfort, there is a
limit of material available, some require special complicated storage techniques, and the degree of predictability is
limited.
Other xenografts and alloplasts have been utilized
as graft materials to offer a substitute to the disadvantage of autogenous graft material.

Boplant, 6 anorganic

bone,7 and boiled cow bone powder 8 were utilized. Also,
9 sc 1 era, 10 ceram1cs,
.
11 and collagen12
.
p 1 as t er o f. par1s,

3
have been used as an alloplast material with some promise.
Mineralized materials acting as a calcium source were
utilized as graft material in periodontal defects in an
attempt to stimulate osteogenesis. 1 3• 14 A pepsin treated
citrate extract of ox bone was found to be a powerful potentiator of new bone formation. 1 5 It was also noted that
ascorbic acid has a critical role in both the formation
and maintenance of collagen in healing wounds. 16
It may be desirable to have both calcium and ascorbate
within a graft material.

A commercially available prepar-

ation, such as calscorbate, * may make available both calcium and ascorbate if used as an alloplast.

The purpose

of this investigation is to determine, on a histologic
level, the sequential healing phenomena of implanted calscorbate powder in two-walled osseous defects, and to observe any histomorphologic changes in the rhesus monkey
periodontium.

*Cole Pharmacal Company

CHAPTER II

REVIEW OF THE LITERATURE

Ascorbic acid has a critical role in both the for.
. t enance o f co 11 agen ~n
. h ea1"~ng woun d s. 16
mat~on
an d ma~n
Proline and hydroxyproline enter the collagen molecule
separately;

both are derived from the proline pool which

is available for this purpose.

Ascorbic acid is probably

involved in both the hydroxylation of proline to hydroxyproline, and lysine to hydroxylysine, and the subsequent
incorporation of these amino acids into the. collagen
molecule •1 7
In 1926, Wolbach18 described the lack of collagen
formation in dentin, bone, and healing wounds during ascorbic acid deficiency states.

And after the administra-

tion of ascorbic acid, a prompt appearance of argyrophilic
fibers followed shortly by fibers having the typical staining characteristics of collagen. 1 9
As early as 1748, Richard Walter 20 described how old
wounds broke open under the influence of scurvy.

Many

other references exist in the older literature which show

4

5
not only that the healing of wounds was delayed but also
21 22
that they were likely to break open again in scurvy. •
2
In 1923, Hojer J suggested that vitamin C was essential
for the maintenance of collagen.
24
In 19JJ, Lauber
found that application of vitamin

c to skin wounds in mice stimulated healing, but that injections of vitamin C into normal guina pigs had no effect
on the speed at which wounds healed.

Thus, it may be

possible that the increased local concentration of vitamin
C as a result of its direct application to the lesion in
animals such as mice (able to synthesize their own vitamin
C) may have enabled the repair process to proceed faster
than if the injured tissues, or tissues undergoing repair,
had been dependent upon the slower diffusion from the blood.
Mann and Pullinger (1940) 25 could not demonstrate that
local applications of vitamin C had a stimulatory effect
on the regeneration of a cornea.
The increased concentration, and possible need, of
vitamin C locally in an injured or repairing area had been
26
They demonstrated
shown by Lauber and Rosenfeld (1938).
a mobilization of vitamin C from the tissues to the injured
region.

Also, the tensile strength of scar tissue was

found to depend directly upon its vitamin C content by

6
Bartlett et al• (1942).

27

In 1937, Lanman and Ingalls

28

were the first to dem-

onstrate a quantitative relationship of the rate of production of intercellular material to the amount of ascorbic
2
acid administered. More recently Wolbach (1953) 9 again
demonstrated this quantitative relationship.
Further studies illustrated the relationship between
vitamin C and collagen production.

In 1936, Jeney and

Toro3° found that in culture media in which fibroblasts
were growing showed a more rapid production with the addition of vitamin C.

Studies on the effect of vitamin C

on skin wounds of guinea pigs showed that the animals receiving the least amount of vitamin C had a greater amount
of reticular (precollagen) fibers than in those receiving
the greatest amount.31 Ham and Elliott (1938)3 2 have illustrated that vitamin C is needed to produce new collagen
fibers but not necessarily to maintain those already formed.
There is a definite relationship between wound healing and vitamin C;33,3 4 ,35 and, as discussed, a definite
relationship between collagen production and vitamin C.
It is uncertain, though, as to the exact mechanism in
which vitamin C deficiency affects collagen production.

7

Wolbach and Howe18 implied that the intercellular
ground substance produced collagen fibers by some sort of
"jellying" process;

and, that in scurvy, it was this "jelly-

ing" process which was affected leaving the cells more or
less normal.

But the lack of understanding of the biochem-

ical function of the vitamin, makes any interpretation of
vitamin C deficiency difficult.
With vitamin C deficiency, it has been shown biochemically and histochemically that there is a decrease in the
activity of oxidative enzymes (cytochrome oxidase and succinic dehydrogenase), and a decrease in phosphatase and
esterase activities.3 6 ,3? Also, there are two major metabolic defects which occur in connective tissue and cartilage in scurvy:

(1) a defect in chondroitin fulfate pro-

duction,38 and (2) a defect in galactosamine formation.39
40
Bates et al. (1969)
noted the effects upon mucopolysaccharide synthesis in ascorbic acid deficiencies.
His study revealed that the granulation tissue formed contained less sulfated glycosaminoglycans and hydroxyproline
compared to the controls.

This suggested that an intimate

relationship existed between these two molecules.

The

decrease in sulfated glycosaminoglycans was attributed to
a lack in galactosamine or the inhibition of glycosamino-

8

glycan synthesis at the protein or polysaccharide level.
Another change in connective tissue in scorbutic
animals is the failure of hydroxylation of proline to
hydroxyproline. 41 Experiments in tissue culture by a
mouse fibroblast line ( T6) showed that ascorbic acid de3
ficiency resulted in half the amount of hydroxyprolinecontaining material being laid down;

thus, supporting the

hypothesis that ascorbic acid affects the intermolecular
cross-linking of collagen through certain hydroxylysine
residues as well as affecting the hydroxylation of proline. 42
Peck et al. (1967) 4 3 indicated that ascorbic acid promotes
collagen synthesis in isolated bone cells by directly stimulating the hydroxylation of a proline-rich peptide.

How

vitamin C facilitates the hydroxylation of proline is not
known, but it appears to be required for the formation of
hydroxyproline and hydroxylysine which are essentially
found only in col~agen. 44
45
.
Hertz (1936)
illustrated that following bone injury
in a completely scorbutic animal, there was no periosteal
hyperemia;

that it is difficult for a scorbutic animal
.
to produce an inflammatory reaction in response to injury;

and the normal process of healing could not be induced.
46
The work of Persson (1953)
further demonstrated

9

the changes in connective tissue with a deficiency of vitamin C.

He noted that there was an increased amount of

ground substance mucopolysaccharides in scurvy, that the
ground substance is in an abnormal state of organization,
and that the water binding capacity uf the skin is increased.
Persson also suggested that local treatment of skin wounds
with ascorbic acid and dehydroascorbic acid may be effective
when the treatment is extended over several days.
. .
47
Ostergaard and Loe (1975)
demonstrated that ascorbic acid is a prerequisite for the maintenance of the
collagen pool in the tissues.
It was also noted that there is a distortion of ri48 in
bosomes in scorbutic fibroblasts. Stassen et a1.

1973, noted a loss of normal configuration in the rough
endoplasmic reticulum.

Addition of ascorbic acid restored

their normal architecture;

thus, suggesting that ascorbate

may exert its action at the proline hydroxylase level.
The addition of ascorbate to cultured fibroblasts induced
a five fold increase in enzymatic activity which was independent of RNA or protein synthesis.
Thus, since vitamin C deficiency is associated with
changes in the connective tissue, and since the principle
elements of connective tissue are also present in bone;

10
it might, therefore, be expected that bone would also be
affected.
It has been shown that ascorbic acid is required for
normal wound healing. 49 Golub (1973) 50 concluded that
ascorbic acid increased bone collagen remodeling in vitro
by favoring the accumulation of newly synthesized bone
collagen and the removal or degradation of the older preformed material.

Embryonic chick tibias grown in tissue

culture displayed a marked dependence upon the presence of
ascorbic acid for normal growth.5l
A citric acid soluble fraction of normal human and
ox bone collagen influences the rate of hydroxyapatite
2
A later study by Solomons and Gregory 53
formation in vitro.5
found that in vitro ability of citrate-soluble collagen
to modify the rate of hydroxyapatite formation was supported in vivo;

and it was concluded that citrate-soluble

collagen accelerated bone mineral deposition. A study by
Hiatt et a1. 1 5 found a citrate extract of ox bone treated
with pepsin, placed in surgically created periodontal
pockets in dogs, resulted in rapid proliferation of repair
cells with accelerated healing in connective tissue, bone,
and cementum.

In addition there was greater amounts of

new bone formation in the healed lesion.

11
Bourne5 4 noted that when calcium ascorbate was injected subcutaneously into rats the amount of bone healing
was statistically increased over that of animals injected
with calcium gluconate.

This may be associated with the

availability of calcium with the ascorbate.

Ramp and

Thornton (1971)55 showed that ascorbic acid increased
calcium turnover in bone, possibly through increased metabolic activity of the bone cells.
In 1923, Robison5 6 first described a local mechanism
of calcification by deposition of the bone mineral from
supersaturated solutions.

Later, in 1934, he stated that

the concept of a local mechanism as an enzyme system did
not preclude the possibility that factors of a different
type, such as surface forces in the colloidal matrix,
might also assist in the deposition of calcium salts.57
The ionic composition of intercellular fluid is
normally supersaturated with respect to calcium and phosphate in the sense that these fluids will lose ions to a
crystal or precipitate of calcium phosphate.5 8 Most calcific deposits consist of crystalline calcium phosphates
in the form of apatite.

But whether crystal formation is

the initial event, that is amorphous calcium phosphates
form first with subsequent crystallization, is still un-

12
settled.5 8

As in bone and cartilage, there are only two

generally considered theories of calcium salt formation.5 9
one states that a high enough local ionic concentration
of calcium and phosphate somehow must accumulate for precipitation to occur.

The other states that some organic

component, collagen in the case of bone, has properties
mimicking those of apatite crystals.

Since the extracell-

ular fluid is supersaturated and metastable with respect to
calcium and phosphate, such an organic structure could
act as a seed crystal and thus as a starting point for a
self-propagating process.

Possibly, both situations may

concurrently occur.
Murry 60 concluded that calcium in the graft was
necessary for the calcification of newly forming bone and
cementum.

He also stated that there is an affinity by the

fibrin clot for calcium

~nd

may thus aid in the retention

of the bone powder.
Beube 61 using heterografts of boiled cow bone powder,
stated that the bone powder may help supplement the calcium
concentration available from the circulatory system.
Linghorne and O'Connell {1951) 62 stated that the
presence of resorbing calcified tissues--the autogenous
implanted bone chips--appeared to be a factor in the dif-

13
ferentiation of osteoblasts.
A number of investigations utilized mineralized
materials acting as a calcium source to stimulate osteogenesis.

Stallard and Randall (1959), 14 Toto et al. (1961)!3

and Glickman and Patur (1962) 63 utilized "anorganic bone";
and Radentz and Collings (1965) 64 utilized plaster. of paris.
The materials offered inconsistent results in relation to
osteogenesis stimulation.
Wadkins et al. (1974) 65 has shown that exposure of
ordinarily noncalcifying matrices in vivo to an unphysiologically high concentration of calcium can produce a
matrix which catalyzed mineral formation.
Ramp and Newman (1973) 66 observed that the ratio
of Ca:Po 4 in the culture media had a direct effect upon
mineralization of explanted chick embryo tibias; thus,
showing that mineralization was more dependent on calcium
than on phosphate ion concentration.

Heeley and Irving

(1973) 67 showed that mineralization begins with formation
of a calcifiable matrix and calcium is the first ion to be
bound.

Groer and Marshall (1973) 68 have shown that the

process of bone surface exchange of calcium takes place
in a layer of bone one to four microns thick.

De Luca

(1967) 69 suggested that vitamin D acts by facilitating

14
the transport of calcium from bone fluid to bone cell.
Better (1972)7° grafted calcium phosphate particles
and tricalcium phosphate as ceramic implant materials.
noted that both materials were well tolerated.

He

Tricalcium

phosphate resorbed the slowest and calcium phosphate the
most rapidly.
In the literature, the present state of knowledge
cannot attribute any single factor to the property of calcifiability.

The postulate exists of a local mechanism

involving both physical and chemical components acting
together in the living organism to bring about calcification.
The source of the osteoblasts have been proposed as
three possible origins: Bruns 71 suggested that they may
arise from pre-existing osteoblasts; Ham and Harris7 2
suggested they arise from the endosteal lining of the marrow
cavities;

and Bloom73 suggested they arise from the pre-

vious two sources and also from the perivascular undifferentiated mesenchymal cells.
Goldhaber (1961)7 4 introduced a concept of an
osteogenic induction factor.

He implanted allogenic neo-

natal skull bone subcutaneously in a millipore diffusion
chamber and found that new bone formation was elicited on
··the host side of the filter.

Thus, new bone was derived

15
from the host tissue in response to a diffusible osteogenic
inductor.
Urist75 termed the "bone induction principle,"
in which a cellular differentiation phenomenon of a tissue
substrate exerts a physio-chemical effect upon competent
mesenchymal cells to stimulate their differentiation into
osteoblasts capable of both osteogenesis and further
induction (autoinduction).
Host site cells may themselves be competent of bone
induction.

Klingsberg (1974)7 6 using scleral grafts in the

repair of periodontal osseous defects in humans, illustrated
an advantageous method to repair destroyed bone.

Re-entry

after two years showed a lasting restoration of the bone
defects after scleral grafting.

The sclera persisted, but

along its edges osteoblasts were present, suggesting that
the sclera was being transformed into bone.

Thus, the

host site cells may themselves be competent of induction.
The graft may just occupy space allowing the prepared host
site to react in a positive manner.
In the investigation of various graft materials, a
number of experimental designs were utilized.

One experi-

mental design, used repeatedly in the past and was selected
for use in this study, utilized surgically created chronic,

16
two-walled periodontal defects in the rhesus monkey.77,7B,79,80
There is substantial evidence in the literature of the
critical role played by ascorbic acid in the formation and
maintenance of collagen.

Also, calcium ascorbate has been

shown to increase the speed of healing.

As was mentioned,

an increased calcium concentration may stimulate osteogenesis.
If a graft material does not itself induce bone formation,
it may offer benefit by occupying space allowing for host
induction.
In view of the evidence provided in the literature, a
study of calscorbate * (containing both calcium and ascorbic
acid) used as an alloplast was undertaken.

The study concerns

itself with the histomorphologic changes in the rhesus monkey periodontium in which an experimental surgical defect
was created and implanted with calscorbate.
*Cole Pharmacal Company, St. Louis, Mo.
Calscorbate Tablets Contain:
Calscorbate Chemically:
Calcium Ascorbate (100mg)
Two Moles Ascorbic Acid
Dibasic Calcium Phosphate
One Mole Calcium
(Hydrous) (1. 08gm)
(C 6H o6 ) ca
2
7
Vitamin D2 (Calciferol)
(50 U.S.P. Units)

CHAPTER III

MATERIALS AND METHODS

A.

EXPERIMENTAL DESIGN
Two adult male rhesus monkeys (Macaca mulatta)

were utilized as experimental models in this study.

The

experiment covered a one-hundred and seven day interval
utilizing the first twenty-one days as a quarantine and
tuberculosis inoculation period.

This period allows the

monkeys to acclimate to the Loyola animal care facility and
a definite parameter of health to be established.

Through-

out the experimental period, the animals maintained their
physical parameters as recorded during their quarantine,
and appeared to remain in good health during the remaining eighty-six days of the experimental period.
The animals demonstrated a slight marginal gingivitis
with varying amounts of materia alba, plaque and calculus.
The gingiva was firm in consistency and pink in color.

The

sulcus depths were examined and noted to be within acceptable limits, one to three millimeters (Figure 1).
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The maxillary and mandibular quadrants were utilized
as experimental sites.
~bular

Thus, four maxillary and four mand-

quadrants were included in the study.

Two, two-

walled surgically created osseous defects per quadrant were
,reated.

Created defects distal to the second bicuspids

were utilized as the control area, and the created defects
distal to the first molars were corrected by calscorbate.
~he

control site preparation and correction (by surgical

curettage without placement of calscorbate implants) was
accomplished at the same time as the preparation of the
analogous implanted defects within the same quadrant.
The one-hundred and seven day schedule of the experiment was planned to allow for a 21 day quarantine and a

86 day experimental period.

This allowed the two-walled

osseous defects to be created thirty days before the initial implantation.

The predetermined schedule was so

designed to allow the sacrifice of the control and the
calscorbate implants on 0, J, 7, 14, 21, 28, 42, and 56
days, postoperatively.
tra~

Each time sequence allowed a con-

experimental defect and a defect corrected by cal-

scorbate.
Twenty minutes prior to the surgical procedures, the
monkey received an intramuscular injection of 8 mg Sernylan*
*Parke, Davis, and Co., Detroit, Michigan

19
for sedation.

When long procedures were encountered, an

additional dose of 5 mg Sernylan was given intramuscularly
as needed for sedation.

Prior to the surgical intervention,

a local anesthetic of Xylocaine 2% * with 1:100,000 epinephrine was used in the area of surgical intervention.
Throughout the course of each surgical procedure,
strict conditions of asepsis were maintained for the operator and the monkeys' protection.

All pertinent clinical

observations were recorded.

B.

GENERAL PREPARATION
Full mucoperiosteal flaps from the distal of the

cuspid to the distal of the second molar were utilized for
both the creation and correction of the defects.

An

intrasulcular incision was carefully performed with a
#15-C Bard-Parker blade and reflected with a small periosteal elevator (#7 wax spatula).

Care was taken so the

tissue would not be perforated, and the incision was scalloped for better primary closure.

Tissue tags on the

inner surface of 'the flap were removed with a small tissue
scissors.

Gracey curettes were used to remove all inter-

proximal granulation tissue and to thoroughly plane the
exposed root surfaces.

20

PREPARATION OF THE DEFECTS
The sites chosen for the creation of the osseous defects were the interproximal osseous septae distal to the
second premolar and the first molar.

These areas offered

a sufficient amount of bone present to allow for the creation of the two-walled defects, and these areas were easily accessible and readily visible.

This experimental area

also affords protection postoperatively due to the interproximal contacts between adjacent teeth, and due to the
contour of the crowns.

The control defect was placed distal

to the second premolar, and the defect created distal to
the first molar received the calscorbate implant.
Two-walled, surgically created, osseous defects
were made in the selected sites.

A 701 tapered fissure

bur was used in a slow speed dental handpiece to remove
J mm of alveolar crest bone, along the distal root surface.

The depth and width of the defect (J mm) was carefully
monitored with the use of a calibrated periodontometer. *
The resulting osseous defects consisted of a lingual and
distal wall of bone, a mesial wall of cementum and/or
dentin and, no buccal wall (Figure 2).

While removing the

bone during the creation of the defects, isotonic saline
*HU-FRIEDY--Michigan probe

r:.....-----------------------,
B':~·

r,;:V~'·'
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~

was used as a coolant to avoid temperature increases which
could damage the bone.

D.

INTRODUCTION OF CHRONIC IRRITANTS
A wooden toothpick approximately 6 mm in length

was introduced into each osseous defect to serve as a
chronic irritant, and the excess afforded a wedging effect
for retention of the toothpick.

The wood acted as a route

of direct communication from the oral cavity to the defect,
allowing bacteria and their toxins ingress.

This was per-

formed in an attempt to simulate a chronic defect seen in
human periodontitis.
The full mucoperiosteal buccal flap was repositioned
and secured close to its original position with interrupted
vertical mattress, interproximal 5-0 Ethaflex * sutures, and
were tied on the lingual surface.

This suturing technique

provided additional stabilization of the chronic irritant.

E.

POSTOPERATIVE CARE
The monkey received a prophylactic injection of an

antibiotic, prior to the ini tiation•. of any surgical pro-

*Ethicon--Johnson and Johnson
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cedure.

An intramuscular injection of 600,000 units (3 cc)

of Combiotic * (Penicillin and dihydrostreptomycin) was
given.

The Combiotic gives a 72 hour antibiotic coverage

to the monkey.

Post-operative instructions specified

that the animals receive no food for the first 24 hours,
a soft diet for the following 2 days, and a normal diet
thereafter.

F.

REMOVAL OF IRRITANTS
Seven days following the creation of the osseous

defects, the animal was sedated, as before with Sernylan,
and the sutures and wooden irritants were removed.
Clinically inflamed gingiva was noted at this time.

G.

PROCUREMENT OF IMPLANT MATERIAL
Calscorbate ** tablets were crushed until a fine,

even consistency powder was obtained.

This Calscorbate

powder without any other modification was utilized as the
implant material.

*Pfizer Company
**Cole Pharmacal Company, Inc.

2.3
H.

CORRECTION OF THE DEFECTS
As outlined previously, the same surgical procedures

were performed.

Exactly .30 days postoperative to the cre-

ation of the two-walled osseous defects, the osseous defects
were exposed for surgical implantation or curettage (in the
case of the control).

All chronic inflammatory tissue was

carefully removed from the previously created two-walled
osseous defects, and the root surfaces were thoroughly
planed.
The control defect on the distal of the second premolar was carefully debrided and irrigated with isotonic
saline, in order to leave the control defect free of any
material.
The powdered calscorbate was placed in the debrided
defect distal to the first molar and overfilled.

The implant

material was allowed to mix with the blood in the defect
area.

The implant material was placed easily, hemorrhage

in the area was well controlled. (Figure

J).

The control area and the implant area were covered
by the full mucoperiosteal flap which was repositioned and
held firmly in place with sutures (as previously described).
The same post-operative antibiotic and diet instructions
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as previously described were given.
Seven days after the surgical correction of the
osseous defects, the animal was again sedated for suture
removal.

The monkey was then maintained until the next

procedure or until the scheduled sacrifice.

I.

COLLECTION OF SPECIMENS
The animals were sedated as previously described

and sacrificed by giving a intra-arterial injection of a
lethal dose of Totaltox. *
A Stryker saw was used to obtain the block sections.
The specimens were washed with distilled water and placed
in pre-labeled jars containing 10% formalin for fixation.
The volume of formalin was 20 times that of the specimen.

J.

PREPARATION FOR HISTOLOGIC EXAMINATION
After two weeks of fixation, each specimen was de-

calcified in formic acid and sodium citrate (50%/50%
solution), trimmed, embedded in paraffin, sectioned at
10 microns in a transverse buccolingual plane, and stained
with hematoxylin and eosin (H&E).

The degree of decalci-

*Chicago Veterinary Supply, Chicago, Illinois
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fication was determined by radiographs taken at weekly
intervals after an initial four week period.

The slides

from each experimental site were stained with hematoxylin
and eosin, and a representative histologic section was
selected for a detailed histologic analysis.

CAA~~IV

FINDINGS

A. CLINICAL OBSERVATIONS
Both monkeys presented with a marginal chronic gingivitis at the initiation of the study (Figure 1).
papillary and marginal gingiva
and magenta in color.
firm and pink in color.

~ppeared

The

somewhat edematous

The attached gingiva was generally
The sulcus depths were within

acceptable limits of one to three millimeters.

Seven days

following the creation of the two-walled osseous defects
and placement of the irritants the gingiva demonstrated
an increased degree of inflammation.

The marginal and

papillary gingiva was edematous, erythematous, and displayed hemorrhage upon probing.

Thirty days following

the creation of the osseous defect, a decrease in the degree of gingival inflammation was noted as compared to
seven days following the creation of the osseous defect,
but greater than at the initiation of the study.
Thirty days after creation, the osseous architecture
of the defects demonstrated additional bone resorption.

26
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The two-walled osseous defects on the buccal cortical plate
showed additional resorption mesially and distally giving
a larger V-shaped defect.
One week after the correction of the defects, the
marginal gingiva was edematous, boggy and erythematous as
compared to adjacent areas.

The tissue inflammation de-

creased by the fourteenth post-operative day and appeared
close to normal.

B.

HISTOLOGIC OBSERVATIONS

1.

INTRODUCTION
Changes'in the epithelium were inflammatory in nature.

The "normal" chronic gingivitis and the result of the surgical insult can be the contributing factors.
The connective tissue initially demonstrated inflammation, followed by repair.

Inflammatory changes

included vasodilation, and inflammatory cell infiltration.
Repair consisted of fibroblastic and endothelial proliferation with re-organization, approaching a normal fibrous
connective tissue.
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2.

TWO-WALLED CONTROL
a.

Epithelium

0 Day
Just prior to sacrifice, the area was surgically flapped and curetted as were all control
defects (3-56 days).

Keratinized stratified

squamous epithelium was present but not adherent
to the tooth.

A normal, thin sulcular epithelium

was discernable with some expected degree of inflammation.

3 Day
Keratinized stratified squamous epithelium
was present over the non-defect area.

The sul-

cular epithelium exhibited some intercellular
edema, some degeneration, and a fibrinopurulent
exudate.

The full mucoperiosteal flap over the

defect area was probably lost in the histologic
preparation.

7 Day
Keratinized stratified squamous epithelium
was present.

Sulcular epithelium of normal thick-

ness and expected inflammatory condition.
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14 Day

(Figure 7)

Keratinized stratified squamous epithelium
was present.

The epithelial attachment was

present (separated in histologic processing).

21 Day

(Figure 10)

The keratinized stratified squamous epithelium and the non-keratinized sulcular epithelium
appeared generally normal with the expected inflammation especially adjacent to the sulcular
epithelium.

28 Day
Keratinized stratified squamous epithelium
was noted.

The section, as cut, could not demon-

strate the epithelial attachment.

42 and 56 Day

(Figure 12)

A keratinized stratified squamous epithelium
was noted.

The "col" area epithelium was thin

as normally expected.

JO
b.

Connective Tissue
0 Day
There was a plasmocytic infiltration and
some edema.

A few small spicules of bone were

noted embedded within the collagen fibers adjacent
to the defect.

Hemorrhage was seen near the de-

tached flap.

(Figure 5)

J Day

The full mucoperiosteal flap was absent from
the sections and probably lost in histologic
preparation.
were present.

Loosely arranged tissue fibers
There is a fibrinopurulent exudate

clot filling the defect;

also, polymorphonuclear

leukocytes were noted.

7 Day

The connective tissue showed some plasma cell
infiltrate, proliferating fibroblasts, and
young capillaries.

14 Day
"Old" collagen and "newly formed" collagen
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were noted especially as the defect was approached.
Inflammatory changes and cellular infiltrate,
especially adjacent to the sulcular epithelium,
were noted.

A fibrous attachment is forming,

getting a reattachment.

New cementum is

forming near the defect.

21 Day
The connective tissue was unremarkable.
The connective tissue repair by fibrogenesis
was generally completed.

28 Day
The lamina propria was composed of mature
connective tissue.

Some degree of inflammation

was noted and expected especially near the epithelium.

42 and 56 Day
The lamina propria shows mature collagen
with some inflammatory changes of slight edema
and some plasma cell infiltration (normal).
There is newly forming periodontal ligament.
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c.

Alveolar Bone and Defect
0 Day

(Figure 4)
The area was surgically flapped and curetted.

The defect was noted in alveolar bone.

Some

small spicules of bone were noted among the
fibrin clot debris.

3 Day

(Figure 5)

Alveolar bone apical to the created defect
showed the periodontal ligament to be attached
to the cementa! surface of the root.

The defect

was filled with a fibrinopurulent exudate,
loosely arranged fibrous connective tissue, and
polymorphonuclear leukocytes.

Active osteo-

genesis with osteoblasts was seen within the
marrow spaces adjacent to the defect area.
Along non-defect bone, osteoblastic activity
was noted.

7 Day

(Figure 6)

The defect area had many proliferating
fibroblasts, young capillaries, and polymorphonuclear leukocytes.

There was residual
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necrotic bone and new bone forming on the surface
of old bone.

Thus, some repair is noted at

seven days.

14 Day
Cementum formed on the root dentin surface adjacent the defect, allowing for a reattachment.

Within the defect there are pro-

liferating and maturing fibroblasts with collagen
fiber bundles being formed.

Some new bone was

forming in the defect, showing active osteoblastis activity.

21 Day

(Figure 10)

Some bone repair in the defect is noted
with osteoblastic activity.

28 Day

(Figure 11)

A small amount of bone regeneration and
osteoblastic activity was noted adjacent to the
more mature bone.

The section, as cut, reveals

a new periodontal ligament fiber attachment to
the newly forming cementum of the tooth.

42 and 56 Day

(Figures 12, 13, and 14)

A small amount of new bone apposition is
noted over the old alveolar bone with active
osteogenesis.

Young collagenous fibers extend

from the new bone to newly formed cementum.

A

fibre-periosteum is noted over new bone.

3.

CALSC ORBATE TWO -WALLED IMPLANT

a.

Epithelium
0 Day
Just prior to sacrifice, the area was
surgically flapped and curetted and calscorbate
implanted into the osseous defect.

Stratified

squamous keratinized epithelium demonstrating a
slight intercellular edema was noted.

3 Day
Stratified squamous keratinized epithelium
was noted.

Over the defect area the specimen

did not show epithelium,

probably due to the

histologic processing and existance of a dense
fibrinopurulent exudate below making a weaker
attachment to the underlying connective tissue.
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7 Day

There was keratinized stratified squamous
epithelium demonstrating slight intercellular
edema.

14 Day
The specimen showed tooth root material
only.

The osseous

and soft tissues were lost

during the histologic preparation.

21 Day
A stratified squamous keratinized epithelium

was noted.

The "col" area epithelium was found

in the section and was thin and not keratinized
as expected.

28 Day

A stratified squamous keratinized epithelium
was noted.

42 and .56 Day
A keratinized stratified squamous epithelium
was noted.

"Col" areas were demonstrated with

normal thin, non-keratinized epithelium.
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b.

Connective Tissue
0 Day
The full mucoperiosteal flap is detached.
The connective tissue shows a plasmacytic infiltration and slight edema.

Extravasated

blood was present between the tooth and flap.

3 Day

(Figures 17, and 18)
The full mucoperiosteal flap was detached.

A fibrinopurulent exudate was present in the
wound site.

Loosely arranged collagen fibers

were noted as well as more mature collagen.
Pigment granules were noted within the lamina
propria at and near the graft site which may
represent hemosiderin pigment or calscorbate
granules or both.

Polymorphonuclear leukocytes

are present and some appear to be phagocytizing
the granular material.

7 Day

(Figure 19)

There is a fibrinopurulent exudate residue
on the surface.

A fibrous connective tissue is

present supporting the epithelium.

There is
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a proliferation of fibroblasts among collagenous
fibers and new capillaries;

thus, a granulomatous

reaction within the connective tissue.

14 Day
The specimen showed tooth root material
only.

The osseous and soft tissues were lost

during the histologic preparation.

21, 28, 42, and 56 Day

(Figure 20)

The connective tissue was repaired.

New,

young collagenous fibers were noted among mature
collagenous fibers.

Many dilated capillaries

and fibroblasts were noted.

In some sections it

was able to demonstrate the extension of collagenous fibers to newly formed cementum.

c.

Alveolar Bone and Defect
0 Day

(Figures 15 and 16)

A defect in the "old" bone is noted.

A

fibrin clot debris, red blood cells, portions of
connective tissue and bone spicules were found
in the prepared defect.

Pigment material which
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may possibly represent hemosiderin and/or
calscorbate implant granules were also noted-this may be described as an amorphous yellowblack pigment in H&E.

3 Day

(Figures 17, and 18)

The pigment granules (possibly hemosiderin
and/or calscorbate) are also seen in the defect
area with red blood cells, polymorphonuclear
leukocytes, and a fibrinopurulent exudate.
The immediate marrow spaces show hyperplasia
with mitosis.

The surviving marrow adjacent to

the wound site shows proliferation.

7 Day

(Figure 19)
There was new bone formation in the defect.

Remodeling is occuring in the area of the
defect and implant.

An acute inflammatory

process, proliferation of fibroblasts and new
capillaries (granulation tissue) exists.

"Old"

bone shows remodeling and resorption with osteoclasts and the surface shows new bone formation
similar to an involucrum.

The bone surface

shows some osteoclastic resorption.

New bone

fr
.
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is found forming around some amorphous debris
(unknown fragments of bone or possibly the
calscorbate granular implant).

14 Day
The specimen showed tooth root material
only.

The osseous and soft tissues were lost

during the histologic preparation.

21 Day

(Figures 20, and 21)

The section demonstrates very active formation of new bone with active osteogenesis on
the surface of the new bone.

The granular

product is most probably calscorbate at this time.

28 Day

(Figures 22, and 23)

Active osteogenesis is still noted.

The

periodontal ligament formation is noted from
newly forming bone to newly formed cementum;
thus, getting a periodontal ligament attachment.

42 Day

(Figure 24)

New bone formation is still occurring with
active osteoblastic activity.

Repair is continuing.
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56 Day

(Figures 25, and 26)

There is a dense new bone formation and
normal periosteum.

The created defect is fill-

ing with new bone with an active periosteum
(the amount of new bone formation appeared
greater than the control).
are seen in the new bone.
lammelated bone.

Wide marrow spaces
There is a dense

.
r

~

'
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CHAPTER V

DISCUSSION

The primary significance of this study demonstrated
that the implant of calscorbate powder is acceptable to
the host.

Calscorbate powder was successfully implanted

in osseous defects of the rhesus monkey with no rejection
phenomena elicited by the host.

Osseous regeneration, re-

attachment, and cementogenesis were noted in the calscorbate
implanted defects.
generation.

The control defects also showed re-

Although a quantative comparison cannot be

made in this study, the amount of bone regeneration in ·
the calscorbate implanted defect appeared comparable or
increased to that of the control.

Important is the fact

that the implanted defects did seem to show a somewhat
delayed sequence of healing as compared to the control.
It should be pointed out that the experimental
defects created in this study attempted to simulate chronic
periodontitis both clinically and histologically.

But the

created defects may not be identical to those found in the
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naturally occurring periodontal disease process.

Nat-

urally occurring periodontal disease can have very complex
and often unknown etiologic factors that cannot be incorporated in the experimental animal model.
The study demonstrated a rapid regeneration of
the gingival epithelium and connective tissue.

As was

already pointed out, ascorbic acid has a critical role in
both the formation and maintenance of collagen in healing
wounds, and may actually stimulate healing.
The dominant cells of the wound are fibroblasts
and endothelial cells.

Epithelium is repaired by mobilization of cel~s from the margin of the wound. 81 The con-

nective tissue of the wound repairs by fibroblastic proliferation and migration of these fibroblasts into the
wound area, and there is a formation and remodeling of the
82
wound's extracellular materia1.
Also, there are definite
proliferative response of the capillaries.

A possible

relationship may exist between the roles of epithelium
and connective tissue in wound healing since the connective
tissue response of endothelial and fibroblastic proliferation is stimulated by epithelial proliferation. 83 Also,
as healing progresses the new connective tissue appears to
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have some inhibitory effect on the proliferation of the
epithelium.
In the repair of bone, the osteoblasts are induced
to produce new bone.

As suggested, they may arise from

pre-existing osteoblasts, from the endosteal lining of
the marrow cavities, and from the perivascular undifferentiated mesenchymal cells. 71 • 72 • 7J The bone induction properties of an implant is of interest, but the initiating
factor of bone formation is not yet known.

It had been

reported that calcium in the graft was necessary for calcification of newly forming bone. 60 It may help supplement
the calcium concentration available from the circulatory
system. 61

And presence of resorbing calcified material

may actually help in the differentiation of osteoblasts. 62
An unphysiologically high concentration of calcium can,
in fact, produce in vivo a matrix which catalyzes mineral
formation. 65

It has been shown that mineralization may

be dependent upon calcium and that calcium is the first
ion to be bound. 67• 68

Also, the rate of bone healing was

increased with calcium ascorbate.5 4
Thus, calscorbate as a graft material may benefit
healing by both the calcium and ascorbate components.
The collagen formation and mineralization may both be

44
favorably affected by the calscorbate implants in relation
to bone repair.
Urist 75 pointed out the possibility of a diffusible
osteogenic inductor for new bone formation.

He also pre-

sented the hypothesis that collagenolytic activity by
histocytes or other cells can cause dissolution of the
organic matrix, yielding an inductor substance for the
formation of new bone which can calcify rapidly.

Also,

the host site has cells, which given the chance, may be
competent of induction of bone.

Further, it might be

stated that any host compatible implant

materia~

cupy space and delay healing of a defect.

can oc-

This would allow

a greater proliferation of granulation tissue with its
increased numbers of undifferentiated mesenchymal cells
when compared to control defects.

Thus, there could be a

greater potential for osteogenesis. This point was brought'
out by Klingsberg76 in the repair of osseous defects in
humans.

He used collagen from sclera as a graft material.

Periodic re-entry, at intervals up to two years, had shown
the sclera graft persisted and active osteogenesis was
present at the graft's edges.

This may represent the

sclera graft was being transformed into new bone.

Thus,

4.5
the scleral graft just "occupied space" and allowed the host
site cells to become competent of induction themselves.
If the calscorbate implant material does not itself
help induce osteogenesis, it may act to occupy space and
delay healing of the defect, thus allowing the chance for
a greater proliferation of granulation tissue with its
undifferentiated mesenchymal cells, allowing the host
site cells to become competent of induction themselves.
Therefore, the fact that the calscorbate implant material
was well tolerated by the host, and that the implanted
defects did seem to show a somewhat delayed sequence of
healing as compared to the control, becomes significant.
Periodontal support includes not only bone but
the periodontal ligament and cementum as well.

It is not

only important to restore bone but also to repair and
restore cementum and periodontal ligament.

The implant-

ed calscorbate did not inhibit cementum formation or the
formation of a periodontal ligament, in fact, its formation appeared somewhat more profound than the control.
And, as mentioned, calscorbate does not interfear with
the induction of osteogenesis and may potentiate it.
It must be recalled that the experimental model used
in this study cannot duplicate the chronic periodontitis
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found in man.

The possible benefit that calscorbate has

been shown within this investigation may not be, therefore,
directly applied to human periodontal therapy (by design
of this investigation).

But a graft material such as

calscorbate would be especially desireable in periodontal
treatment because it is readily available, would involve
a single surgical procedure, and is not believed to be
immunologically sensitive as other osseous grafting
techniques may be.

CHAPTER VI

CONCL USI ONS

1.

The two-walled osseous defects corrected by

calscorbate were accepted by the host site and did not
impede osteogenesis.
2.

The experimental defects utilized in this study

attempted to simulate chronic periodontitis.

But the

experimental animal model may not allow for a direct relationship to the c.hronic periodontitis in man.

J.

Possibly, the calscorbate material implant acts

as a "space occupier'' allowing for a greater number of
undifferentiated mesenchymal cells and host induction of
osteogenesis.

4.

Possibly, the calscorbate may influence the bone

collagen, and provide· a calcium source to the healing defect.

5.

The control areas treated by surgical curettage

showed osseous healing analagous to the calscorbate corrected defects.

Perhaps a larger sampling might show

accelerated bone deposition by calscorbate.
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CHAPTER VII

SUlVIMARY

This study was conducted to examine histologically
the sequential healing phenomena in chronic two-walled
periodontal osseous defects following their correction
with calscorbate implants.
Two male adult rhesus monkeys were utilized as
experimental models providing specimens from 0 to 56 days
postoperatively.

Both control and graft specimens were taken

at 0, J, 7, 14, 21, 28, 42, and 56 days.

The control

surgical defect was treated by surgical curettage only.
Commercially available calscorbate tablets were
uniformily crushed to a powder and utilized as the experimental implant into the surgically created defects.
Histologic sections from each specimen were stained
with Hand E, a description of the sequential healing events
were recorded, and the results discussed.
The implanted calscorbate was compatible with osteogenesis.

The material was well accepted by the host
48
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site and did not impede osteogenesis.

A quantative

relationship of the implant material to the control
cannot be made, though the implant material did appear to
have a more profound amount of bone repair over the control:

r ___________________________
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CHAPTER VIII
ILLUSTRATIONS
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Figure 1.

The preoperative

e xperimental area.
marg inal ging ivitis.

appe~rance

of the

Note the sli g ht papillary and
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Figure 2.

Experimentally created two-walled

osseous defects (arrows) distal to the second
premolar (control) and the first molar (area
to receive the graft.
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Figure J,

Placement of calscorbate implant

(overfilled) in the defect area distal to the
first molar and the control area is distal to
the second premolar.
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Figure 4.

0 day flapped control, 4ox.

Surgically created defect with fibrin clot debris
showing pieces of connective tissue and spicules
of bone (arrows).

55

Figure 5.

3 day control, 4ox.

The defect area is filled with a fibropurulent
exudate (a).
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Figure 6.

7 day control, 4ox.

The defect has many proliferating fibroblasts.
New bone (n) is forming over old bone (o).
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Figure 7.

14 day control, lOx.

Stratified squamous epithelium (e), epithelial
attachment (a), and new collagen (c) as defect
is approached.
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Figure 8.

14 day control, 25x.

Cementum formed on the dental surface (arrow).
New bone formation (b).

-----------------~--------------·--------------------------------------.
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Figure 9.

14 day control, 4ox.

Active osteoblastic activity (o).
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Figure 10.

21 day control 40x.

Keratinized stratified squamous epithelium (e).
Some new bone repair (b), and osteoblastic
activity (o).

61

Figure 11.

28 day control, 4ox.

Newly formed periodontal ligament (1), to
newly formed cementum (c), osteoblastic activity
(o) adjacent the more mature bone.
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Figure 12.

42 day control, 25x.

Keratinized stratified squamous epithelium (e),
new bone formation (b).

Figure 13.

42 day control, 40x.

New bone with active osteogenesis (arrow).

64

Figure 14.

56 day control, 4ox.

Defect area with some new bone (b), a fibroperiosteum is noted over the new bone (arrow).
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Figure

15.

0 day calscorbate implant,

Prepared defect in o ld bone.

25x.

Fibrin clot debris (a).
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Figure 16.

0 day calscorbate implant, 40x.

Prepared defect with fibrin clot debris.
Portion of connective tissue remnant (a), spicule
of bone (b), and pigmented material (arrow).
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Fi gure 17.

J day calscorbate implant, 25x.

Fibrinopurulent exudate (a), l oo sely arranged
collagen fibers (b ).
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Figure 18.

J day calscorbate implant, 4ox.

Fibrinopurulent exudate (a), fibrous connective
tissue (b), and pigment granules (arrow).
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Figure 19.

7 day calscorbate implant, 25x.

New bone formation (a) in the defect, and fibrous
connective tissue (b).

7.0

Figure 20.

21 day calscorbate implant, 25x.

Active formation of new bone (a), and fibrous
connective tissue (b).
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Figure 21.

21 day calscorbate implant, 4ox.

Newly formed bone and osteoblastic activity (a),
"old" bone (b).
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Figure 22.

28 day calscorbate implant, 25x.

Periodontal ligament (1), from newly formed
bone (b), to new cementum (c).
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Figure 23.

28 day calscorbate implant 4ox.

Newly forming bone and osteogenesis (a) .

r
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Figure 24 .

42 day calscorbate implant, 4ox.

New bone formation and osteoblastic activity (arrow).
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Figure 25.

56 day calscorbate implant, 40x.

Note dense new bone filling defect (a).

I
I
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Figure 26.

56 day calscorbate implant, 4ox.

Note dense new bone filling the defect (a),

i

I

I

and osteoblastic activity (arrow).
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APPENDIX

GRAFT TERMINOLOGY

Old

Definition

New

Autograft

Autograft

same individual

Isograft

Synograft

identical twins

Homograft

Allograft

within same species

Heterograft

Xenograft

different species

Alloplast

bone substitute
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